BridgeBio Pharma
BBIO
$29.97
Share price
3.52%
Change (1 day)
101.95%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.88 B
According to BridgeBio Pharma 's latest financial reports the company's total liabilities are $1.88 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BridgeBio Pharma - Total liabilities on balance sheet (from 2018 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.88 B | 1.12% |
| 2022-12-31 | $1.86 B | -0.55% |
| 2021-12-31 | $1.87 B | 215.32% |
| 2020-12-31 | $0.59 B | 282.59% |
| 2019-12-31 | $0.15 B | 77.79% |
| 2018-12-31 | $87.57 M | -42.66% |
| 2017-12-31 | $0.15 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.62 B | -67.00% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.01 M | -99.36% | 🇺🇸 USA |